e-learning
resources
Munich 2006
Sunday 03.09.2006
COPD and systemic inflammation
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Determinants of heightened systemic inflammation at exacerbation of COPD
J. R. Hurst, G. C. Donaldson, W. R. Perera, T. M. Wilkinson, G. W. Hagan, R. S. Vessey, J. A. Wedzicha (London, United Kingdom; Philadelphia, United States Of America)
Source:
Annual Congress 2006 - COPD and systemic inflammation
Session:
COPD and systemic inflammation
Session type:
Oral Presentation
Number:
754
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. R. Hurst, G. C. Donaldson, W. R. Perera, T. M. Wilkinson, G. W. Hagan, R. S. Vessey, J. A. Wedzicha (London, United Kingdom; Philadelphia, United States Of America). Determinants of heightened systemic inflammation at exacerbation of COPD. Eur Respir J 2006; 28: Suppl. 50, 754
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Endothelial dysfunction and systemic inflammation during acute exacerbations of COPD
Source: International Congress 2016 – Biomarkers and phenotypes of COPD
Year: 2016
Relationship between systemic inflammation and rhythmicity of acute exacerbations of COPD
Source: Virtual Congress 2021 – Biomarkers for the management of bronchial obstructive diseases
Year: 2021
Endothelial dysfunction and systemic inflammation during acute exacerbations of COPD
Source: Annual Congress 2012 - COPD is not a pulmonary disease alone
Year: 2012
Systemic inflammation and systemic oxidative stress in patients with acute exacerbations of COPD
Source: Annual Congress 2007 - Pathophysiology and assessment of COPD
Year: 2007
Local and systemic inflammation in acute viral exacerbations of COPD
Source: Eur Respir J 2005; 26: Suppl. 49, 251s
Year: 2005
Modulation of airway inflammation to prevent exacerbations of COPD
Source: Eur Respir Rev 2005; 14: 78-82
Year: 2005
Systemic inflammation and systemic oxidative stress in acute COPD exacerbation
Source: Annual Congress 2010 - Novel markers of lung injury
Year: 2010
Markers of severity and inflammatory profile during exacerbations of severe asthma.
Source: International Congress 2017 – Airway disease and exacerbations
Year: 2017
Acceleration of neutrophilic inflammation during COPD exacerbation
Source: Eur Respir J 2002; 20: Suppl. 38, 505s
Year: 2002
Inflammatory changes, recovery and recurrence at COPD exacerbation
Source: Eur Respir J 2007; 29: 527-534
Year: 2007
Cachexia in patients with acute COPD exacerbations: relationship to pulmonary function, systemic inflammation and oxidative stress
Source: Annual Congress 2008 - Comorbidities in COPD
Year: 2008
Hyperglycemia is associated with poor outcomes in patients with acute exacerbations of chronic obstructive pulmonary disease
Source: Annual Congress 2013 –COPD biomarkers
Year: 2013
Association of systemic inflammation with clinical recovery in patients with acute exacerbation of COPD
Source: Annual Congress 2011 - Phenotyping and monitoring of airway diseases
Year: 2011
Change in inflammation during COPD exacerbations
Source: Eur Respir J 2005; 26: Suppl. 49, 15s
Year: 2005
Time course of systemic inflammatory markers during acute exacerbation of COPD
Source: Eur Respir J 2007; 30: Suppl. 51, 555s
Year: 2007
Effect of systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease
Source: Eur Respir J 2006; 28: Suppl. 50, 624s
Year: 2006
Determinants of depression at exacerbation in chronic obstructive pulmonary disease
Source: Eur Respir J 2007; 30: Suppl. 51, 557s
Year: 2007
Association between airway inflammation and systemic inflammation in stable chronic obstructive pulmonary disease
Source: Annual Congress 2010 - COPD: systemic inflammation and comorbidities
Year: 2010
Biomarkers in the management of COPD
Source: Eur Respir Rev 2009; 18: 96-104
Year: 2009
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept